Healthcare

Pharmaceutical Logistics Market Size is Forecasted to Reach US$ 159.14 Bn by 2030

The global pharmaceutical logistics market size is forecasted to reach from US$ 77.57 billion in 2021 to US$ 159.14 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 8.3% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The pharmaceutical logistics market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decision to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1443

The growing demand for the overthecounter (OTC) medicines such as supplements, minerals, vitamins, common cough, gastrointestinal pharmaceuticals, and cold remedies products is also contributing to the expansion of the pharmaceutical logistics industry. Pharmaceutical logistics is being driven by the growing need of fast-track support in the healthcare industry. Furthermore, lowering distribution costs by establishing a single-source distribution channel is driving up demand for pharmaceutical logistics.

Mergers and acquisitions are being used by a huge number of companies to increase their geographical reach and proprietary knowledge. They’re also concentrating on lowering their product’s overall packaging expenses. The hazards of product adulteration during transportation, as well as non-compliance with federal regulations, standards, and guidelines, are especially prevalent in the biotechnology and pharmaceutical supply chains.

Scope of the Pharmaceutical Logistics Market

Report Coverage Details
Market Size in 2021 USD 77.57 Billion
Growth Rate CAGR of 8.3% From 2021 to 2030
Revenue Projection by 2030 USD 159.14 Billion
Largest Market Europe
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Component, Region

Competitive Landscape Analysis:

Some of the leading companies operating in the pharmaceutical logistics market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Major companies operating in this report are

  • FedEx
  • Agility
  • CEVA Logistics
  • Deutsche Post AG
  • VersaCold Logistics Services
  • LifeConEx
  • Air Canada
  • United Parcel Service of America Inc.
  • DB Schenker
  • Marken

Market Dynamics

Drivers

Increase in refrigerated warehouses

The hundreds of warehouses with cold chain systems are being built to ensure the best possible storage and transit conditions for temperature-sensitive products. The crucial links that the cold chain solutions system provides are vital to a variety of export sectors. Due to end-to-end cold chain security is the weak link in the system; businesses invest millions of dollars to build efficient, effective, and dependable processes. A single disruption in the logistics system can result in capital losses and catastrophic products. Additionally, the demand for online pharmacies is increasing their demand for cold storage. Thus, the increase in refrigerated warehouses is driving the growth of pharmaceutical logistics market during the forecast period.

Restraints

Lack of standardization

The lack of standards and accreditations causes substantial issues for the pharmaceutical logistics market, which is currently concerned about the quality and flexibility of available warehouse spaces. In many circumstances, the enterprises must invest additional funds to update the facility and its specifications to industry-specific standards that support their operations. Thus, the lack of standardization is the restricting factor for the growth of pharmaceutical logistics market during the forecast period.

Opportunities

Growth in pharmaceutical industry

Pharmaceutical companies are concentrating efforts on product quality and sensitivity. Increased creation of more sophisticated biological-based medications and vaccinations that require cold storage must all be carried at a controlled temperature, which can be accomplished using cold chain logistics. The broader healthcare logistics business is seeing significant increase in transportation and delivery of temperature-controlled pharmaceutical products and drugs. The pharmaceutical logistics industry will need to respond swiftly to rising volume, sensitivity, and quality standards of commodities, as well as ever-increasing restrictions. As a result, growth in pharmaceutical industry is creating lucrative opportunities for the growth of pharmaceutical logistics market during the forecast period.

Challenges

High operational cost of cold chain logistics

The cold chain logistics market uses a lot of electricity on a daily basis. As a result of the rising cost of consumed energy, cold chain service providers are finding it difficult to reduce their operational costs. Furthermore, high energy and real estate expenses are likely to make the planning and implementation process difficult. Thus, the high operational costs of cold chain logistics is a huge challenge for the growth of pharmaceutical logistics market during the forecast period.

Report Highlights

  • Based on the type, the cold chain logistics segment dominated the global pharmaceutical logistics market in 2020 with highest market share. Over the projected period, strict government restrictions to maintain precise temperature for extremely temperature-sensitive pharmaceutical items are expected to drive market expansion. Telematics is becoming more widely used in cold chain pharmaceutical logistics, allowing businesses to improve the efficiency, connectivity, and safety or their transport goods. During the manufacturing and distribution stages, most biological and medicinal products require a temperature-controlled environment, which aids in maintaining the medications’ effectiveness and purity. As a result, pharmaceutical businesses employ temperature-controlled transportation and storage systems.

Regional Snapshot

Europe is the largest segment for pharmaceutical logistics market in terms of region. The significant growth in the pharmaceutical product trade across key European countries is responsible for the high market share. The UK, Germany, and France are among them. Furthermore, the rising production and demand for a variety of pharmaceutical products, such as over the counter (OTC) medicines, in the Europe region is expected to drive the market’s expansion.

Asia-Pacific region is the fastest growing region in the pharmaceutical logistics market. Due to high economic expansion in emerging nations such as India and China, the market for pharmaceutical logistics in the Asia-Pacific is expected to rise rapidly over the forecast period. The pharmaceutical logistics market in Asia-Pacific is predicted to grow because to the high demand for the over the counter (OTC) drugs among a large population.

Segments Covered in the Report

By Type

  • Cold Chain Logistics
  • Non-cold Chain Logistics

By Component

  • Storage
    • Warehouse
    • Refrigerated container
  • Transportation
    • Sea freight Logistics
    • Airfreight Logistics
    • Overland Logistics
  • Monitoring components
    • Hardware
      • Sensors
      • RFID Devices
      • Telematics
      • Networking Devices
    • Software

By Application

  • Bio Pharma
  • Chemical Pharma
  • Speciality Pharma

By Procedure

  • Picking
  • Storage
  • Retrieval Systems
  • Handling Systems

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global pharmaceutical logistics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmaceutical logistics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1443

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmaceutical Logistics Market 

5.1. COVID-19 Landscape: Pharmaceutical Logistics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmaceutical Logistics Market, By Type

8.1. Pharmaceutical Logistics Market, by Type, 2021-2030

8.1.1. Cold Chain Logistics

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Non-cold Chain Logistics

8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Pharmaceutical Logistics Market, By Component

9.1. Pharmaceutical Logistics Market, by Component, 2021-2030

9.1.1. Storage

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Transportation

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Monitoring components

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Pharmaceutical Logistics Market, By Application Type 

10.1. Pharmaceutical Logistics Market, by Application Type, 2021-2030

10.1.1. Bio Pharma

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Chemical Pharma

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Speciality Pharma

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Pharmaceutical Logistics Market, By Procedure Type 

11.1. Pharmaceutical Logistics Market, by Procedure Type, 2021-2030

11.1.1. Picking

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Storage

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Retrieval Systems

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Handling Systems

11.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Pharmaceutical Logistics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2019-2030)

12.1.2. Market Revenue and Forecast, by Component (2019-2030)

12.1.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.1.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Component (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.1.5.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Component (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.1.6.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2019-2030)

12.2.2. Market Revenue and Forecast, by Component (2019-2030)

12.2.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Component (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.5.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Component (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.6.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Component (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.7.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Component (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.8.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2019-2030)

12.3.2. Market Revenue and Forecast, by Component (2019-2030)

12.3.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Component (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.5.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Component (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.6.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Component (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.7.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Component (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.8.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2019-2030)

12.4.2. Market Revenue and Forecast, by Component (2019-2030)

12.4.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Component (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.5.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Component (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.6.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Component (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.7.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Component (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.8.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2019-2030)

12.5.2. Market Revenue and Forecast, by Component (2019-2030)

12.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.5.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Component (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.5.5.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Component (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.5.6.4. Market Revenue and Forecast, by Procedure Type (2019-2030)

Chapter 13. Company Profiles

13.1. FedEx

13.1.1. Company Overview

13.1.2. Product Offering

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agility

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. CEVA Logistics

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Deutsche Post AG

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. VersaCold Logistics Services

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. LifeConEx

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Air Canada

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. United Parcel Service of America Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. DB Schenker

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Marken

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1443

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button